Evaluating the frequency of asymptomatic Ebola virus infection

The potential for asymptomatic infection from Ebola viruses has long been questioned. Knowing the proportion of infections that are asymptomatic substantially changes the predictions made by mathematical models and alters the corresponding decisions based upon these models. To assess the degree of a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Philosophical transactions of the Royal Society of London. Series B. Biological sciences 2017-05, Vol.372 (1721), p.20160303-20160303
Hauptverfasser: Mbala, Placide, Baguelin, Marc, Ngay, Ipos, Rosello, Alicia, Mulembakani, Prime, Demiris, Nikolaos, Edmunds, W. John, Muyembe, Jean-Jacques
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 20160303
container_issue 1721
container_start_page 20160303
container_title Philosophical transactions of the Royal Society of London. Series B. Biological sciences
container_volume 372
creator Mbala, Placide
Baguelin, Marc
Ngay, Ipos
Rosello, Alicia
Mulembakani, Prime
Demiris, Nikolaos
Edmunds, W. John
Muyembe, Jean-Jacques
description The potential for asymptomatic infection from Ebola viruses has long been questioned. Knowing the proportion of infections that are asymptomatic substantially changes the predictions made by mathematical models and alters the corresponding decisions based upon these models. To assess the degree of asymptomatic infection occurring during an Ebola virus disease (EVD) outbreak, we carried out a serological survey in the Djera district of the Equateur province of the Democratic Republic of the Congo affected by an Ebola outbreak in 2014. We sampled all asymptomatic residents (n = 182) of 48 households where at least one case of EVD was detected. To control for potential background seroprevalence of Ebola antibodies in the population, we also sampled 188 individuals from 92 households in an unaffected area with a similar demographic background. We tested the sera collected for anti-Ebola IgG and IgM antibodies at four different dilutions. We then developed a mixture model to estimate the likely number of asymptomatic patients who developed IgM and IgG responses to Ebola antigens in both groups. While we detected an association between medium to high titres and age, we did not detect any evidence of increased asymptomatic infection in the individuals who resided in the same household as cases. This article is part of the themed issue ‘The 2013–2016 West African Ebola epidemic: data, decision-making and disease control’.
doi_str_mv 10.1098/rstb.2016.0303
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1098_rstb_2016_0303</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1891877134</sourcerecordid><originalsourceid>FETCH-LOGICAL-c595t-d8e530f7621f5023dfd50228f075f21131f06515123ee59fbf2a12347a6da7e83</originalsourceid><addsrcrecordid>eNqNkc9rFDEUx4Modq1ePcqAFy-z5iWTX5eCLasWCgWt55CdSdrUmcmaZBbGv96s25a2oPSUwPu8z8vLF6G3gJeAlfwYU14vCQa-xBTTZ2gBjYCaKIGfowVWnNSyofwAvUrpGmOsmGheogMiqeKNaBboaLU1_WSyHy-rfGUrF-2vyY7tXAVXmTQPmxyGUm6r1Tr0ptr6OKXKj8622YfxNXrhTJ_sm5vzEP34vLo4-VqfnX85Pfl0VrdMsVx30jKKneAEHMOEdq4rB5EOC-YIAAWHOQMGhFrLlFs7Ysq9EYZ3RlhJD9HR3ruZ1oPtWjvmaHq9iX4wcdbBeP2wMvorfRm2mlHV8AaK4MONIIayYMp68Km1fW9GG6akQSqQQgBtnoBKLhglnBT0_SP0OkxxLD-hQUlanESKQi33VBtDStG6u3cD1rsU9S5FvUtR71IsDe_ub3uH38ZWALoHYpjLsNB6m-d7s_-l_fm_rm_fL463VBAPgoDGkgIWQErzb7_Zq0pR-5Qmq_8iD_WPp_0BNIPMJw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1983891287</pqid></control><display><type>article</type><title>Evaluating the frequency of asymptomatic Ebola virus infection</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>PubMed Central</source><creator>Mbala, Placide ; Baguelin, Marc ; Ngay, Ipos ; Rosello, Alicia ; Mulembakani, Prime ; Demiris, Nikolaos ; Edmunds, W. John ; Muyembe, Jean-Jacques</creator><creatorcontrib>Mbala, Placide ; Baguelin, Marc ; Ngay, Ipos ; Rosello, Alicia ; Mulembakani, Prime ; Demiris, Nikolaos ; Edmunds, W. John ; Muyembe, Jean-Jacques</creatorcontrib><description>The potential for asymptomatic infection from Ebola viruses has long been questioned. Knowing the proportion of infections that are asymptomatic substantially changes the predictions made by mathematical models and alters the corresponding decisions based upon these models. To assess the degree of asymptomatic infection occurring during an Ebola virus disease (EVD) outbreak, we carried out a serological survey in the Djera district of the Equateur province of the Democratic Republic of the Congo affected by an Ebola outbreak in 2014. We sampled all asymptomatic residents (n = 182) of 48 households where at least one case of EVD was detected. To control for potential background seroprevalence of Ebola antibodies in the population, we also sampled 188 individuals from 92 households in an unaffected area with a similar demographic background. We tested the sera collected for anti-Ebola IgG and IgM antibodies at four different dilutions. We then developed a mixture model to estimate the likely number of asymptomatic patients who developed IgM and IgG responses to Ebola antigens in both groups. While we detected an association between medium to high titres and age, we did not detect any evidence of increased asymptomatic infection in the individuals who resided in the same household as cases. This article is part of the themed issue ‘The 2013–2016 West African Ebola epidemic: data, decision-making and disease control’.</description><identifier>ISSN: 0962-8436</identifier><identifier>EISSN: 1471-2970</identifier><identifier>DOI: 10.1098/rstb.2016.0303</identifier><identifier>PMID: 28396474</identifier><language>eng</language><publisher>England: The Royal Society</publisher><subject>Adolescent ; Adult ; Antibodies ; Antibodies, Viral - blood ; Antigens ; Asymptomatic Infection ; Asymptomatic Infections - epidemiology ; Decision making ; Democratic Republic of the Congo - epidemiology ; Demographics ; Dilution ; Disease control ; Ebola virus ; Ebola Virus Disease ; Ebolavirus ; Ebolavirus - physiology ; Epidemics ; Female ; Hemorrhagic Fever, Ebola - epidemiology ; Hemorrhagic Fever, Ebola - virology ; Household Survey ; Households ; Humans ; Immunoglobulin G ; Immunoglobulin G - blood ; Immunoglobulin M ; Immunoglobulin M - blood ; Infections ; Male ; Mathematical models ; Models, Theoretical ; Outbreaks ; Prevalence ; Seroepidemiologic Studies ; Serology ; Viral diseases ; Viruses ; Young Adult</subject><ispartof>Philosophical transactions of the Royal Society of London. Series B. Biological sciences, 2017-05, Vol.372 (1721), p.20160303-20160303</ispartof><rights>2017 The Author(s)</rights><rights>2017 The Author(s).</rights><rights>Copyright The Royal Society Publishing May 26, 2017</rights><rights>2017 The Author(s) 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c595t-d8e530f7621f5023dfd50228f075f21131f06515123ee59fbf2a12347a6da7e83</citedby><cites>FETCH-LOGICAL-c595t-d8e530f7621f5023dfd50228f075f21131f06515123ee59fbf2a12347a6da7e83</cites><orcidid>0000-0003-3867-1953</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394641/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394641/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28396474$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mbala, Placide</creatorcontrib><creatorcontrib>Baguelin, Marc</creatorcontrib><creatorcontrib>Ngay, Ipos</creatorcontrib><creatorcontrib>Rosello, Alicia</creatorcontrib><creatorcontrib>Mulembakani, Prime</creatorcontrib><creatorcontrib>Demiris, Nikolaos</creatorcontrib><creatorcontrib>Edmunds, W. John</creatorcontrib><creatorcontrib>Muyembe, Jean-Jacques</creatorcontrib><title>Evaluating the frequency of asymptomatic Ebola virus infection</title><title>Philosophical transactions of the Royal Society of London. Series B. Biological sciences</title><addtitle>Phil. Trans. R. Soc. B</addtitle><addtitle>Philos Trans R Soc Lond B Biol Sci</addtitle><description>The potential for asymptomatic infection from Ebola viruses has long been questioned. Knowing the proportion of infections that are asymptomatic substantially changes the predictions made by mathematical models and alters the corresponding decisions based upon these models. To assess the degree of asymptomatic infection occurring during an Ebola virus disease (EVD) outbreak, we carried out a serological survey in the Djera district of the Equateur province of the Democratic Republic of the Congo affected by an Ebola outbreak in 2014. We sampled all asymptomatic residents (n = 182) of 48 households where at least one case of EVD was detected. To control for potential background seroprevalence of Ebola antibodies in the population, we also sampled 188 individuals from 92 households in an unaffected area with a similar demographic background. We tested the sera collected for anti-Ebola IgG and IgM antibodies at four different dilutions. We then developed a mixture model to estimate the likely number of asymptomatic patients who developed IgM and IgG responses to Ebola antigens in both groups. While we detected an association between medium to high titres and age, we did not detect any evidence of increased asymptomatic infection in the individuals who resided in the same household as cases. This article is part of the themed issue ‘The 2013–2016 West African Ebola epidemic: data, decision-making and disease control’.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antibodies</subject><subject>Antibodies, Viral - blood</subject><subject>Antigens</subject><subject>Asymptomatic Infection</subject><subject>Asymptomatic Infections - epidemiology</subject><subject>Decision making</subject><subject>Democratic Republic of the Congo - epidemiology</subject><subject>Demographics</subject><subject>Dilution</subject><subject>Disease control</subject><subject>Ebola virus</subject><subject>Ebola Virus Disease</subject><subject>Ebolavirus</subject><subject>Ebolavirus - physiology</subject><subject>Epidemics</subject><subject>Female</subject><subject>Hemorrhagic Fever, Ebola - epidemiology</subject><subject>Hemorrhagic Fever, Ebola - virology</subject><subject>Household Survey</subject><subject>Households</subject><subject>Humans</subject><subject>Immunoglobulin G</subject><subject>Immunoglobulin G - blood</subject><subject>Immunoglobulin M</subject><subject>Immunoglobulin M - blood</subject><subject>Infections</subject><subject>Male</subject><subject>Mathematical models</subject><subject>Models, Theoretical</subject><subject>Outbreaks</subject><subject>Prevalence</subject><subject>Seroepidemiologic Studies</subject><subject>Serology</subject><subject>Viral diseases</subject><subject>Viruses</subject><subject>Young Adult</subject><issn>0962-8436</issn><issn>1471-2970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc9rFDEUx4Modq1ePcqAFy-z5iWTX5eCLasWCgWt55CdSdrUmcmaZBbGv96s25a2oPSUwPu8z8vLF6G3gJeAlfwYU14vCQa-xBTTZ2gBjYCaKIGfowVWnNSyofwAvUrpGmOsmGheogMiqeKNaBboaLU1_WSyHy-rfGUrF-2vyY7tXAVXmTQPmxyGUm6r1Tr0ptr6OKXKj8622YfxNXrhTJ_sm5vzEP34vLo4-VqfnX85Pfl0VrdMsVx30jKKneAEHMOEdq4rB5EOC-YIAAWHOQMGhFrLlFs7Ysq9EYZ3RlhJD9HR3ruZ1oPtWjvmaHq9iX4wcdbBeP2wMvorfRm2mlHV8AaK4MONIIayYMp68Km1fW9GG6akQSqQQgBtnoBKLhglnBT0_SP0OkxxLD-hQUlanESKQi33VBtDStG6u3cD1rsU9S5FvUtR71IsDe_ub3uH38ZWALoHYpjLsNB6m-d7s_-l_fm_rm_fL463VBAPgoDGkgIWQErzb7_Zq0pR-5Qmq_8iD_WPp_0BNIPMJw</recordid><startdate>20170526</startdate><enddate>20170526</enddate><creator>Mbala, Placide</creator><creator>Baguelin, Marc</creator><creator>Ngay, Ipos</creator><creator>Rosello, Alicia</creator><creator>Mulembakani, Prime</creator><creator>Demiris, Nikolaos</creator><creator>Edmunds, W. John</creator><creator>Muyembe, Jean-Jacques</creator><general>The Royal Society</general><general>The Royal Society Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7SN</scope><scope>7SS</scope><scope>7TK</scope><scope>C1K</scope><scope>7X8</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3867-1953</orcidid></search><sort><creationdate>20170526</creationdate><title>Evaluating the frequency of asymptomatic Ebola virus infection</title><author>Mbala, Placide ; Baguelin, Marc ; Ngay, Ipos ; Rosello, Alicia ; Mulembakani, Prime ; Demiris, Nikolaos ; Edmunds, W. John ; Muyembe, Jean-Jacques</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c595t-d8e530f7621f5023dfd50228f075f21131f06515123ee59fbf2a12347a6da7e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antibodies</topic><topic>Antibodies, Viral - blood</topic><topic>Antigens</topic><topic>Asymptomatic Infection</topic><topic>Asymptomatic Infections - epidemiology</topic><topic>Decision making</topic><topic>Democratic Republic of the Congo - epidemiology</topic><topic>Demographics</topic><topic>Dilution</topic><topic>Disease control</topic><topic>Ebola virus</topic><topic>Ebola Virus Disease</topic><topic>Ebolavirus</topic><topic>Ebolavirus - physiology</topic><topic>Epidemics</topic><topic>Female</topic><topic>Hemorrhagic Fever, Ebola - epidemiology</topic><topic>Hemorrhagic Fever, Ebola - virology</topic><topic>Household Survey</topic><topic>Households</topic><topic>Humans</topic><topic>Immunoglobulin G</topic><topic>Immunoglobulin G - blood</topic><topic>Immunoglobulin M</topic><topic>Immunoglobulin M - blood</topic><topic>Infections</topic><topic>Male</topic><topic>Mathematical models</topic><topic>Models, Theoretical</topic><topic>Outbreaks</topic><topic>Prevalence</topic><topic>Seroepidemiologic Studies</topic><topic>Serology</topic><topic>Viral diseases</topic><topic>Viruses</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mbala, Placide</creatorcontrib><creatorcontrib>Baguelin, Marc</creatorcontrib><creatorcontrib>Ngay, Ipos</creatorcontrib><creatorcontrib>Rosello, Alicia</creatorcontrib><creatorcontrib>Mulembakani, Prime</creatorcontrib><creatorcontrib>Demiris, Nikolaos</creatorcontrib><creatorcontrib>Edmunds, W. John</creatorcontrib><creatorcontrib>Muyembe, Jean-Jacques</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Philosophical transactions of the Royal Society of London. Series B. Biological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mbala, Placide</au><au>Baguelin, Marc</au><au>Ngay, Ipos</au><au>Rosello, Alicia</au><au>Mulembakani, Prime</au><au>Demiris, Nikolaos</au><au>Edmunds, W. John</au><au>Muyembe, Jean-Jacques</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluating the frequency of asymptomatic Ebola virus infection</atitle><jtitle>Philosophical transactions of the Royal Society of London. Series B. Biological sciences</jtitle><stitle>Phil. Trans. R. Soc. B</stitle><addtitle>Philos Trans R Soc Lond B Biol Sci</addtitle><date>2017-05-26</date><risdate>2017</risdate><volume>372</volume><issue>1721</issue><spage>20160303</spage><epage>20160303</epage><pages>20160303-20160303</pages><issn>0962-8436</issn><eissn>1471-2970</eissn><abstract>The potential for asymptomatic infection from Ebola viruses has long been questioned. Knowing the proportion of infections that are asymptomatic substantially changes the predictions made by mathematical models and alters the corresponding decisions based upon these models. To assess the degree of asymptomatic infection occurring during an Ebola virus disease (EVD) outbreak, we carried out a serological survey in the Djera district of the Equateur province of the Democratic Republic of the Congo affected by an Ebola outbreak in 2014. We sampled all asymptomatic residents (n = 182) of 48 households where at least one case of EVD was detected. To control for potential background seroprevalence of Ebola antibodies in the population, we also sampled 188 individuals from 92 households in an unaffected area with a similar demographic background. We tested the sera collected for anti-Ebola IgG and IgM antibodies at four different dilutions. We then developed a mixture model to estimate the likely number of asymptomatic patients who developed IgM and IgG responses to Ebola antigens in both groups. While we detected an association between medium to high titres and age, we did not detect any evidence of increased asymptomatic infection in the individuals who resided in the same household as cases. This article is part of the themed issue ‘The 2013–2016 West African Ebola epidemic: data, decision-making and disease control’.</abstract><cop>England</cop><pub>The Royal Society</pub><pmid>28396474</pmid><doi>10.1098/rstb.2016.0303</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-3867-1953</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0962-8436
ispartof Philosophical transactions of the Royal Society of London. Series B. Biological sciences, 2017-05, Vol.372 (1721), p.20160303-20160303
issn 0962-8436
1471-2970
language eng
recordid cdi_crossref_primary_10_1098_rstb_2016_0303
source Jstor Complete Legacy; MEDLINE; PubMed Central
subjects Adolescent
Adult
Antibodies
Antibodies, Viral - blood
Antigens
Asymptomatic Infection
Asymptomatic Infections - epidemiology
Decision making
Democratic Republic of the Congo - epidemiology
Demographics
Dilution
Disease control
Ebola virus
Ebola Virus Disease
Ebolavirus
Ebolavirus - physiology
Epidemics
Female
Hemorrhagic Fever, Ebola - epidemiology
Hemorrhagic Fever, Ebola - virology
Household Survey
Households
Humans
Immunoglobulin G
Immunoglobulin G - blood
Immunoglobulin M
Immunoglobulin M - blood
Infections
Male
Mathematical models
Models, Theoretical
Outbreaks
Prevalence
Seroepidemiologic Studies
Serology
Viral diseases
Viruses
Young Adult
title Evaluating the frequency of asymptomatic Ebola virus infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T21%3A59%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluating%20the%20frequency%20of%20asymptomatic%20Ebola%20virus%20infection&rft.jtitle=Philosophical%20transactions%20of%20the%20Royal%20Society%20of%20London.%20Series%20B.%20Biological%20sciences&rft.au=Mbala,%20Placide&rft.date=2017-05-26&rft.volume=372&rft.issue=1721&rft.spage=20160303&rft.epage=20160303&rft.pages=20160303-20160303&rft.issn=0962-8436&rft.eissn=1471-2970&rft_id=info:doi/10.1098/rstb.2016.0303&rft_dat=%3Cproquest_cross%3E1891877134%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1983891287&rft_id=info:pmid/28396474&rfr_iscdi=true